Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis

1st Apr 09

Release Date: 01/04/2009 12:00am

Pharmaceutical company Pharmaxis (ASX:PXS, NASDAQ:PXSL) today announced completion of the first component of its Phase III international trial assessing the effectiveness of Bronchitol in people with cystic fibrosis.

View PDF

Categories: